Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
25.91
+0.07 (0.27%)
Mar 6, 2026, 4:00 PM EST - Market closed
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.68 billion as of March 6, 2026. Its market cap has increased by 84.18% in one year.
Market Cap
1.68B
Enterprise Value
1.30B
1-Year Change
84.18%
Ranking
Category
Stock Price
$25.91
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.68B, an increase of 164.31%. That is a compound annual growth rate of 21.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 1.68B | -6.88% |
| Dec 31, 2025 | 1.80B | 73.39% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vericel | 1.69B |
| Relay Therapeutics | 1.69B |
| Trevi Therapeutics | 1.68B |
| Olema Pharmaceuticals | 1.68B |
| Sarepta Therapeutics | 1.67B |
| Immunocore Holdings | 1.64B |
| Innoviva | 1.63B |
| Novavax | 1.62B |